A multicenter, single-arm phase II study of pemetrexed plus doxorubicin administered every 21 days in patients with advanced breast cancer
- Martin, M.
- Blasinska-Morawiec, M.
- Salas, J.F.
- Falcon, S.
- Rolski, J.
- Ferrari, B.L.
- Gulyas, S.
- Liu, Y.
- Benhadji, K.A.
ISSN: 1526-8209
Argitalpen urtea: 2009
Alea: 9
Zenbakia: 3
Orrialdeak: 155-160
Mota: Artikulua